2B70:XETRA-iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) EUR (EUR)

ETF | Others | XETRA

Last Closing Price

EUR 5.41

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.28M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-03-07 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
XJSE:XETRA Xtrackers II Japan Government .. 0.15 %

N/A

EUR126.27B
SXRZ:XETRA iShares VII PLC - iShares Nikk.. 0.48 %

N/A

EUR36.37B
VUSA:XETRA Vanguard S&P 500 UCITS ETF 0.00 %

N/A

EUR28.20B
VUAA:XETRA Vanguard S&P 500 UCITS ETF.. 0.00 %

N/A

EUR28.20B
WHC:XETRA Weyerhaeuser Co 0.00 %

N/A

EUR20.87B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (.. 0.51 %

N/A

EUR19.32B
PEU:XETRA Stellantis N.V 0.00 %

N/A

EUR16.84B
JDE:XETRA JDE Peets NV 0.00 %

N/A

EUR16.46B
EL44:XETRA Deka MSCI Japan UCITS ETF 0.50 %

N/A

EUR15.10B
IS3N:XETRA iShares Core MSCI EM IMI UCITS.. 0.18 %

N/A

EUR13.76B

ETFs Containing 2B70

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Others)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.98% 11% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.98% 11% F 16% F
Trailing 12 Months  
Capital Gain 16.52% 62% D- 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.52% 62% D- 58% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.66% 82% B- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.66% 81% B- 71% C-
Risk Return Profile  
Volatility (Standard Deviation) 11.38% 35% F 54% F
Risk Adjusted Return 67.30% 82% B- 81% B-
Market Capitalization N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.